Health
Daiichi Sankyo says it has begun producing AstraZeneca’s COVID-19 vaccine in Japan – TheChronicleHerald.ca
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan. The drugmaker said in a release it…
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan.
The drugmaker said in a release it will prepare the vaccine in Japan, including vial filling and packaging, using the bulk solution provided by AstraZeneca.
The Japanese government has already arranged to buy 120 million doses of AstraZeneca’s vaccine, enough for 60 million people. Most of the doses will be made in Japan by Daiichi Sankyo, JCR Pharma and other local partners.
…
-
Noosa News23 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News24 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General10 hours agoGrieving parents of 4yo boy who drowned in Officer suing Melbourne Water, Cardinia council
-
Business24 hours agoWhat’s next for this lithium stock?